Table of Contents

Oncology

• Clinical

  • 

    You have access

    ¹¹C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence

    Asim K. Bag, Melissa N. Wing, Noah D. Sabin, Scott N. Hwang, Gregory T. Armstrong, Yuanyuan Han, Yimei Li, Scott E. Snyder, Giles W. Robinson, Ibrahim Qaddoumi, Alberto Broniscer, John T. Lucas and Barry L. Shulkin

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 664-671; DOI: https://doi.org/10.2967/jnumed.120.261891
  • 

    Open Access

    Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer

    Jasper Vonk, Jaron G. de Wit, Floris J. Voskuil, Yang Hang Tang, Wouter T.R. Hooghiemstra, Matthijs D. Linssen, Evert van den Broek, Jan J. Doff, Sebastiaan A.H.J. de Visscher, Kees-Pieter Schepman, Bert van der Vegt, Gooitzen M. van Dam and Max J.H. Witjes

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 672-678; DOI: https://doi.org/10.2967/jnumed.121.262530
  • 

    You have access

    ⁹⁰Y Radioembolization in the Treatment of Neuroendocrine Neoplasms: Results of an International Multicenter Retrospective Study

    Benedikt M. Schaarschmidt, Moritz Wildgruber, Roman Kloeckner, James Nie, Verena Steinle, Arthur J.A.T. Braat, Fabian Lohoefer, Hyun S. Kim, Harald Lahner, Manuel Weber and Jens Theysohn

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 679-685; DOI: https://doi.org/10.2967/jnumed.121.262561
  • 

    You have access

    PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer

    Jasper Smit, Frank J. Borm, Anna-Larissa N. Niemeijer, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Daniela E. Oprea-Lager, Danielle J. Vugts, Guus A.M.S. van Dongen, Berlinda J. de Wit-van der Veen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 686-693; DOI: https://doi.org/10.2967/jnumed.121.262473
  • 

    You have access

    Biodistribution of ¹⁸F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader

    Ramsha Iqbal, Maqsood Yaqub, Daniela E. Oprea-Lager, Yeukman Liu, Anne Marije Luik, Andy P. Beelen, Robert C. Schuit, Albert D. Windhorst, Ronald Boellaard and Catharina W. Menke-van der Houven van Oordt

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 694-699; DOI: https://doi.org/10.2967/jnumed.121.262500

  • INVITED PERSPECTIVE

    • You have access

      ER Imaging for Estrogen-Related Tumors Is Bothersome but Useful

      Hidehiko Okazawa

      Journal of Nuclear Medicine May 1, 2022, 63 (5) 700-701; DOI: https://doi.org/10.2967/jnumed.121.263170
  • 

    You have access

    ¹⁸F-4FMFES and ¹⁸F-FDG PET/CT in Estrogen Receptor–Positive Endometrial Carcinomas: Preliminary Report

    Michel Paquette, Esteban Espinosa-Bentancourt, Éric Lavallée, Serge Phoenix, Korine Lapointe-Milot, Paul Bessette, Brigitte Guérin and Éric E. Turcotte

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 702-707; DOI: https://doi.org/10.2967/jnumed.121.262617
  • 

    You have access

    ¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma

    Joseph G. Crompton, Wesley R. Armstrong, Mark A. Eckardt, Ameen Seyedroudbari, William D. Tap, Sarah M. Dry, Evan R. Abt, Jeremie Calais, Ken Herrmann, Johannes Czernin, Fritz C. Eilber and Matthias R. Benz

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 708-712; DOI: https://doi.org/10.2967/jnumed.121.262502
  • 

    You have access

    Detection of Additional Primary Neoplasms on ¹⁸F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer

    Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti and Richard L. Wahl

    Journal of Nuclear Medicine May 1, 2022, 63 (5) 713-719; DOI: https://doi.org/10.2967/jnumed.121.262647

  • FEATURED ARTICLE OF THE MONTH

    • 

      You have access

      CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of ⁸⁹Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody

      Michael D. Farwell, Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian Wilson, Michael S. Gordon, Anna M. Wu, Gary A. Ulaner, Jedd D. Wolchok, Michael A. Postow and Neeta Pandit-Taskar

      Journal of Nuclear Medicine May 1, 2022, 63 (5) 720-726; DOI: https://doi.org/10.2967/jnumed.121.262485